Steven Barilla, MD
Dermatology · Hollywood, FLNPI 1700382256
Payments from drug & device makers
Across 185 payments — averaging $92.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$12K
- AbbVie$1K
- E.r. Squibb & Sons, L.L.C.$680
- Regeneron Healthcare Solutions, Inc.$522
- Sanofi$470
- Johnson & Johnson$375
- plus $2K from 15 others
What the payments were for
- Speaking & faculty fees$12,00070%
- Food & beverage$5,07030%
- Education$1111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 14 | $12,436 |
| AbbVie | 58 | $1,037 |
| E.r. Squibb & Sons, L.L.C. | 6 | $680 |
| Regeneron Healthcare Solutions, Inc. | 20 | $522 |
| Sanofi | 15 | $470 |
| Johnson & Johnson | 11 | $375 |
| Sun Pharmaceutical Industries Inc. | 5 | $373 |
| Arcutis Biotherapeutics, Inc. | 23 | $243 |
| Dermavant Sciences, Inc. | 4 | $242 |
| Lilly USA, LLC | 8 | $186 |
| Fresenius Kabi USA, LLC | 1 | $167 |
| Amgen | 4 | $103 |
| UCB, Inc. | 3 | $87 |
| Incyte Corporation | 3 | $66 |
| LEO Pharma Inc. | 3 | $59 |
| Novartis | 2 | $38 |
| Organon | 1 | $24 |
| Pfizer | 1 | $22 |
| Biofrontera Inc. | 1 | $20 |
| Organogenesis Inc. | 1 | $17 |
| Kerecis Limited | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,181 in reported general payments places this provider in the 80th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 76 | $2,426 |
| Ketoconazole | 57 | $1,107 |
| Triamcinolone Acetonide | 73 | $995 |
| Ammonium Lactate | 40 | $736 |
| Clindamycin Phosphate | 16 | $562 |
| Doxycycline Hyclate | 27 | $296 |
| Mometasone Furoate | 18 | $250 |
| Mupirocin | 38 | $248 |
| Hydrocortisone | 40 | $197 |
| Cephalexin | 23 | $180 |
| ValacyclovirValacyclovir Hcl | 15 | $177 |
| Minoxidil | 21 | $76 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hollywood
- Eduardo WeissHollywood$5.5M
- Michael SherlingLake Worth$78.9M
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
- Hector Wiltz JrMiami$6.4M
- Javier Alonso-LlamazaresCoral Gables$5.6M
- Francisco KerdelMiami$5.1M
- Jason SluzevichJacksonville$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.